Trial Details

Authorised
Basic Information
Clinical ID c5144
Identifier EUCTR2005-005414-20-IT
Trial Title Randomized controlled double-blind Vs. placebo multicentre study on the safety and effectiveness of thalidomide in the treatment of refractory Crohn s disease and ulcerative colitis. - Thalidomide and IBD
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease Crohn Disease, Ulcerative Colitis MedDRA version: 6.1.Level: PT.Classification code 10021972.
Interventions Trade Name: Thalidomide PharmionPharmaceutical Form: Capsule, hardINN or Proposed INN: ThalidomideConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Capsule,
Participant Information
Sponsor ISTITUTO PER L INFANZIA BURLO GAROFOLO
City NULL
Country/Region Italy
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL